Tổng số lượt xem trang

Thứ Bảy, 7 tháng 9, 2013

VECTOR FLOW MAPPING, HITACHI-ALOKA

Ultrasound expands its role in cardiac imaging with disruptive applications. Cardiac diagnostics is entering a zone of turbulence. Manufacturers of leading systems continue to mine data from the sonic signal that opens new fields for research. John Brosky from European Hospital reports.

By merging the stunning three-dimensional (3-D) images with traditional X-ray, new systems are providing novel capabilities for diagnosis and navigation. ‘I believe that 3-D echo is the cornerstone for the non-invasive diagnosis of cardiac diseases,’ says Jose Zamorano MD, head of Cardiology at the University Hospital Ramón y Cajal in Madrid. ‘. You can see the anatomy of the heart, and you can see the function.’ He cites as an example the turbulence created by blood flow in the cavities of the heart that is now revealed by technology called vector flow mapping developed by Hitachi-Aloka.
Turbulence as the most important unsolved problem of classical physics [ Richard Feynman ]. It may also be the key to unlocking unsolved problems in cardiac diagnosis.
 Dr Zamorano said. ‘We can now see the vectors and the vortices for normal blood flow, and we have seen the way turbulence is affected by abnormal physiology and different pathologies… What is certain is that this will help in evaluation, and it could become a prognostic indication for the patient. It opens a new area of research to correlate what we are observing with the pathologies of patients.’

Vector flow mapping is an innovative ultrasound application derived from colour Doppler velocity data that adds new mathematical methods to display flow distribution without angle dependency.
‘With vector flow mapping you truly can see how the blood behaves entering the left ventricle and how it is ejected into the system.’ In the case of an aortic stenosis, he pointed out that the turbulence which appears in the left ventricle outflow is characteristic and ‘absolutely different from a normal patient’.

In the cardiovascular research facility in Madrid, he is currently testing a new advance in fusion imaging developed by Toshiba for its CardioVascularFusion (CVI-Fusion) system that creates a revolutionary capability for the assessment of ischaemia. ‘At ESC we will reveal a new technique, one that is quite unique, and which no one else is doing,’ he promised. ‘We will demonstrate the feasibility of using stress echo in fusion imaging, which in my opinion becomes crucial. Stress echo induces ischaemia, but here for the first time we will show the ischaemia. ‘By combining these views we can see the stenosis, the location of the stenosis and now how the stenosis impacts on the prognosis.’

Opening a window on the heart

Recent advances in echocardiography, especially tissue Doppler imaging and speckle tracking, have sharpened the focus on cardiac muscle. Yet, there has not been a link established between the observed blood flow and morphological patterns in the myocardium and cardiac cavities. Now that link is being observed and quantified using a novel and non-invasive technique developed by Hitachi Aloka called Vector Flow Mapping (VFM).

‘With vector flow you really see how blood behaves, which is not something we have seen before,’ explained Jose Zamorano MD. Contracting muscle fibres and the chambers of the heart create vortices and turbulence that are specific to patient pathologies, he added. In his studies using VFM he has documented how the turbulence inside the left ventricle is different and characteristic if the patient presents with a disease such as severely depressed ejection fraction after an infarction compared to a patient with a normal left ventricle but an aortic stenosis. VFM begins with velocity data derived from colour Doppler echography to generate velocity fields on a 2-D image. Engineers at Hitachi Aloka then moved beyond data received in the direction of the beam by applying unique algorithms that enable an estimation of the radial component. Now the flow distribution can be displayed without angle dependency. In addition to displaying flow distribution through vectors, VFM also provides the mainstream lines. The application can detect and display the intra-cardiac vortices and quantify the different parameters.
Suddenly a window on the heart opens to reveal the intricate interactions at the interface between pulsing blood and cardiac fibres. This data can be visualised, measured and analysed across a complex array of parameters that describe the spatial and temporal distribution of blood flow. In other words, this data can be translated into diagnostic and prognostic information to inform clinical decisions, according to Partho Sengupta MD, lead author of an article entitled, ‘Emerging Trends in CV Flow Visualisation,’ published in the Journal of the American College of Cardiology.

Dr Jose Luis Zamorano Gomez Profile: Jose Luis Zamorano Gomez MD is the Head of Cardiology at the University Hospital Ramón y Cajal in Madrid. A Fellow of the European Society of Cardiology (ESC), currently he is the Chair of the ESC Guidelines Committee and a past-President of the European Association of Echocardiography of the ESC.








Thứ Tư, 4 tháng 9, 2013

FATTY LIVER and IBS

ABSTRACT:

     Non-alcoholic fatty liver disease (NAFLD) and irritable bowel syndrome (IBS) are two very common diseases in the general population. To date, there are no studies that highlight a direct link between NAFLD and IBS, but some recent reports have found an interesting correlation between obesity and IBS.
        A systematic PubMed database search was conducted highlighting that common mechanisms are involved in many of the local and systemic manifestations of NAFLD, leading to an increased cardiovascular risk, and IBS, leading to microbial dysbiosis, impaired intestinal barrier and altered intestinal motility. It is not known when considering local and systemic inflammation/immune system activation, which one has greater importance in NAFLD and IBS pathogenesis. Also, the nervous system is implicated. In fact, inflammation participates in the development of mood disorders, such as anxiety and depression, characteristics of obesity and consequently of NAFLD and, on the other hand, in intestinal hypersensitivity and dysmotility.